Registered number
11186063
S M PHARM LTD
Filleted Accounts
28 February 2025

S M PHARM LTD
Registered number: | 11186063
Balance Sheet
as at 28 February 2025
Notes |  |  | 2025 |  |  | 2024
£ | £
Current assets
Debtors | 3 |  | 100 |  |  | 100
Cash at bank and in hand |  |  | 2,500 |  |  | 13,338
|  |  | 2,600 |  |  | 13,438
Creditors: amounts falling due within one year | 4 |  | 1,994 |  |  | 5,403
Net current assets |  |  |  | 4,594 |  |  | 18,841
Net assets |  |  |  | 4,594 |  |  | 18,841
Capital and reserves
Called up share capital |  |  |  | 100 |  |  | 100
Profit and loss account |  |  |  | 4,494 |  |  | 18,741
Shareholder's funds |  |  |  | 4,594 |  |  | 18,841
The director is satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The member has not required the company to obtain an audit in accordance with section 476 of the Act.
The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Mr Stefano Mirabello
Director
Approved by the board on 6 October 2025

S M PHARM LTD
Notes to the Accounts
for the year ended 28 February 2025
1 | Accounting policies
| Basis of preparation
| The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
| Turnover
| Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
2 | Employees | 2025 |  | 2024
Number | Number
| Average number of persons employed by the company | 2 |  | 2
3 | Debtors | 2025 |  | 2024
£ | £
| Other debtors | 100 |  | 100
4 | Creditors: amounts falling due within one year | 2025 |  | 2024
£ | £
| Taxation and social security costs | 7,213 |  | 12,006
| Other creditors | (9,207) |  | (17,409)
|  |  |  |  |  | (1,994) |  | (5,403)
5 | Other information
| S M PHARM LTD is a private company limited by shares and incorporated in England. Its registered office is:
| 11 Wisteria Drive
| Crawley
| RH10 3GX

S M PHARM LTD 11186063 false 2024-03-01 2025-02-28 2025-02-28 VT Final Accounts April 2025 Mr Stefano Mirabello No description of principal activity 11186063 2023-03-01 2024-02-29 11186063 core:WithinOneYear 2024-02-29 11186063 core:ShareCapital 2024-02-29 11186063 core:RetainedEarningsAccumulatedLosses 2024-02-29 11186063 2024-03-01 2025-02-28 11186063 bus:PrivateLimitedCompanyLtd 2024-03-01 2025-02-28 11186063 bus:AuditExemptWithAccountantsReport 2024-03-01 2025-02-28 11186063 bus:Director40 2024-03-01 2025-02-28 11186063 countries:England 2024-03-01 2025-02-28 11186063 bus:FRS102 2024-03-01 2025-02-28 11186063 bus:FilletedAccounts 2024-03-01 2025-02-28 11186063 2025-02-28 11186063 core:WithinOneYear 2025-02-28 11186063 core:ShareCapital 2025-02-28 11186063 core:RetainedEarningsAccumulatedLosses 2025-02-28 11186063 2024-02-29 iso4217:GBP xbrli:pure